The story cut through the panic to inform primary care physicians of their colleagues’ practical reactions to a meta-analysis linking the diabetes drug Avandia with an increased heart attack risk. Avandia had been a popular drug, so there was real concern about potential negative effects on the many patients taking it. A companion piece gave physicians an in-depth look at the research on Avandia to date.
